ESG risk score 20.59
Environmental score 3.69
Social score 12.11
Governance score 4.79
ESG risk category Medium
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Eli Lilly & Co.
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol LLY:xnys
Currency USD
New York Stock Exchange
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) -19.21%
1 year -1.84%
3 years 122.43%
Data provided by 
Key stats
Price/earnings (LTM) 38.44
Dividend yield (LTM) 0.69%
EPS (LTM) 22.59
Volatility (30 days) 32.77%
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Eli Lilly & Co.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Sector Healthcare
Industry -
Market cap 826bn
Data provided by /
/ Eli Lilly and Co. (LLY) is a US-based pharmaceutical company that develops, manufactures, and markets medicines in key therapeutic areas, including diabetes, oncology, immunology, neuroscience, and obesity. Founded in 1876 and headquartered in Indianapolis, Indiana, the company is one of the largest pharmaceutical groups globally.
Its product portfolio includes widely prescribed treatments for diabetes and obesity, such as insulin products and incretin-based therapies, as well as innovative medicines for cancer and autoimmune diseases. Lilly has also advanced research in Alzheimer's disease and other central nervous system conditions.
The company invests heavily in research and development, maintaining laboratories and clinical programmes worldwide. It distributes its medicines in more than 100 countries, supported by a broad network of partnerships with research institutions and healthcare providers.
Eli Lilly and Co. is listed on the New York Stock Exchange (NYSE).
Data provided by 
Saxo provides this content for general information only. It is not intended as personal advice, an offer, or a recommendation. Saxo does not guarantee accuracy or completeness and accepts no liability for losses. Consider obtaining independent advice before any investment decision.
Others were interested in
See all stocksFrequently asked questions
To buy Eli Lilly & Co. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Eli Lilly & Co. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Eli Lilly & Co. is LLY:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Eli Lilly & Co. has its primary listing on New York Stock Exchange. You can trade Eli Lilly & Co. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Eli Lilly & Co. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Eli Lilly & Co. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Eli Lilly & Co. or others.